Eastgate Biotech Corp.
ETBI
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -3.82M | -2.71M | -2.47M | -2.98M | -3.23M |
| Total Depreciation and Amortization | 73.70K | -- | -- | -- | 13.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 505.70K | 626.90K | 737.50K | 1.02M | 280.10K |
| Change in Net Operating Assets | 1.49M | 2.02M | 1.33M | 1.57M | 2.71M |
| Cash from Operations | -1.75M | -62.00K | -402.40K | -384.40K | -233.90K |
| Capital Expenditure | -51.70K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -51.70K | -- | -- | -- | -- |
| Total Debt Issued | 1.77M | 412.60K | 374.50K | 326.60K | 222.00K |
| Total Debt Repaid | -145.90K | -67.60K | -8.10K | -10.10K | -8.40K |
| Issuance of Common Stock | 191.90K | 191.90K | -- | -- | 20.00K |
| Repurchase of Common Stock | -71.90K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.75M | 536.90K | 366.40K | 316.50K | 233.50K |
| Foreign Exchange rate Adjustments | 60.20K | 64.40K | 34.60K | 48.70K | 400.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.80K | 539.10K | -1.50K | -19.20K | 0.00 |